Ayurcann Holdings Corp. (CSE:AYUR) (OTCQB:AYURF) (FSE:3ZQ0) reported its financial results Monday for the three and nine months ended March 31, 2024. For the third fiscal quarter, the Toronto-based company earned net revenue of CA$6.49 million ($4.76 million), compared to CA$2.85 million in the same period last year.
During the last six months, the company secured 24 new stock keeping units in the vape, pre-roll and concentrate categories in Ontario, Alberta, Manitoba, Saskatchewan and British Columbia and began selling in Newfoundland and Yukon.
More about investments and financial data from the industry you can hear at the 19th Benzinga Cannabis Capital Conference in Chicago this October 8-9. Engage with top executives, investors, policymakers, and advocates to explore the industry's future. Secure your tickets now before prices increase by following this link.
Fiscal Q3 Financial Highlights
- Gross revenue increased to CA$11,66 million, compared to CA$5.89 million for the same period last year, representing an increase of 97%.
- Net loss amounted to CA$349,581 or CA$0.002 per share, versus a net loss of CA$1.05 million or CA$0.007 per share in the same quarter last year.
- Adjusted EBITDA was a gain of CA$271,813, which compares to an adjusted EBITDA loss of CA$744,328, for the same periods last year.
- Gross margin, calculated based on net revenue, was 37%.
- Expenses amounted to CA$2.72 million, up from CA$1.88 million in the same period of fiscal 2023.
Price Action
Ayurcann shares closed Friday market session 1.21% higher at $0.03 per share.
Canadian Cannabis Companies Could See Valuations Soar By Up To 300% With Tax Reform, New Report Shows
Photo: Courtesy of SD_FlowerPower via Shutterstock